NCT00928278View on ClinicalTrials.gov

A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Healthy
Interventions
DRUG

Treatment A

Inhaled, 300/150, single dose

DRUG

Treatment B

Inhaled, 300/150, single dose

DRUG

Treatment C

Inhaled, 300/150, single dose + oral activated charcoal block

DRUG

Treatment D

Inhaled, 300/150, single dose + oral activated charcoal block

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY